Unlock instant, AI-driven research and patent intelligence for your innovation.

Synthetic method of avibactam intermediate

A synthetic method and intermediate technology, which is applied in the field of synthesis of avibactam intermediates, can solve the problems of cumbersome routes, relatively expensive, and no absolute configuration of compounds, etc., and achieve the effect of mild reaction conditions and simple operation

Pending Publication Date: 2022-01-21
SHANGHAI YANAN PHARMA HUBEI CO LTD +1
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Patent FR2001007520 discloses a method for synthesizing avibactam, but this method does not give the absolute configuration of the compound: Novexel made some improvements to the synthesis of avibactam, but the route is cumbersome and the stereoselectivity is not good: AstraZeneca Published a process route for the synthesis of avibactam. The reagents used in this synthesis route, such as CDI and Fmoc-Cl, are expensive and have poor stereoselectivity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic method of avibactam intermediate
  • Synthetic method of avibactam intermediate
  • Synthetic method of avibactam intermediate

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0036] The invention provides a kind of synthetic method of avibactam intermediate, comprising steps:

[0037] (1) Under the protection of an inert gas, dissolve the compound (II) in the first solvent to obtain the first mixed solution, add alkali to the first mixed solution, and undergo ring closure at -78 to 110°C Reaction, the reaction reaction time is 1~72h, and compound (Ⅲ) is obtained;

[0038] (2) Dissolving the compound (III) in a second solvent to obtain a second mixed solution, adding an acid to the second mixed solution, and a decarbonylation protection reaction occurs at an environment of 20-110° C., reaction 1~ 72h, obtained compound (Ⅳ);

[0039] (3) Dissolving the compound (IV) in a third solvent to obtain a third mixed solution, adding a reducing agent to the third mixed solution, and a carbonyl reduction reaction occurs at 0-50° C. 10h, compound (I) was obtained;

[0040] The synthetic route of compound (I) is as follows:

[0041]

[0042] in:

[0043]...

Embodiment 1

[0057] Preparation of Compound (Ⅲ)

[0058] Under the protection of argon, 4.0 g of (S)-methyl 6-bromo-2-((tert-butoxycarbonyl)amino)-5,5-dimethoxyhexanoate was dissolved in 25 mL of dry tetrahydrofuran, At 0°C, 5 batches of 100 mg each were added with 500 mg of sodium hydride in total, and the reaction was carried out at room temperature for 12 h. The reaction was detected by TLC, and 40 mL of water was slowly added at 0°C to quench the reaction, and the aqueous layer was extracted 4 times with dichloromethane, each time 40 mL of dichloromethane, and the combined organic phase was washed once with 50 mL of saturated aqueous sodium bicarbonate solution, and anhydrous magnesium sulfate After drying, the solvent was spin-off and the light yellow oil obtained by separation with a silica gel column was compound (Ⅲ) (65% yield).

[0059] figure 1 is compound (Ⅲ) hydrogen spectrogram; figure 2 It is the carbon spectrum of compound (Ⅲ).

[0060] 1 H NMR (400MHz, Chloroform-d) δ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a synthesis method of an avibactam intermediate. The method comprises the following steps: cyclizing a chiral substrate under an alkaline condition, removing carbonyl protection under an acidic condition, and reducing carbonyl by using a reducing agent to obtain the avibactam intermediate (2S, 5S)-5-hydroxypiperidine-1, 2-dicarboxylate. According to the method, conventional reagents are used, conditions are stable and controllable, operation is easy and safe, raw materials are easy to obtain, the yield is high, reaction aftertreatment is simple, and potential industrial application value is achieved.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry synthesis, and in particular relates to a synthesis method of an avibactam intermediate. Background technique [0002] Avibactam (NXL-104) belongs to the diazabicyclooctone compound and is currently the most promising non-β-lactam β-lactamase inhibitor, which can inhibit type A (including ESBL and KPC) And C-type β-lactamases, avibactam has broad-spectrum antibacterial activity when used in combination with various cephalosporins and carbapenem antibiotics. [0003] Patent FR2001007520 discloses a method for synthesizing avibactam, but this method does not give the absolute configuration of the compound: Novexel made some improvements to the synthesis of avibactam, but the route is cumbersome and the stereoselectivity is not good: AstraZeneca Published a process route for the synthesis of avibactam. The reagents used in this synthesis route, such as CDI and Fmoc-Cl, are relatively expensive and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D211/60
CPCC07D211/60
Inventor 陈芬儿唐培杨智蒋龙李亚玲
Owner SHANGHAI YANAN PHARMA HUBEI CO LTD